Devices and methods for clip separation

Information

  • Patent Grant
  • 12171486
  • Patent Number
    12,171,486
  • Date Filed
    Monday, May 3, 2021
    4 years ago
  • Date Issued
    Tuesday, December 24, 2024
    7 months ago
Abstract
A device configured to cut leaflet tissue at a cardiac valve may comprise a guide catheter having a proximal end and a distal end, the guide catheter being positionable at a cardiac valve. The device may further include a cutting mechanism routable through the guide catheter and configured to extend from the distal end of the guide catheter, the cutting mechanism configured to cut a portion of leaflet tissue of the cardiac valve. Finally, the device may comprise a handle coupled to the proximal end of the guide catheter, the handle comprising at least one control operatively connected to the cutting mechanism such that the at least one control is configured to provide selective actuation of the cutting mechanism.
Description
BACKGROUND OF THE INVENTION

The mitral valve controls blood flow from the left atrium to the left ventricle of the heart, preventing blood from flowing backwards from the left ventricle into the left atrium so that it is instead forced through the aortic valve for delivery of oxygenated blood throughout the body. A properly functioning mitral valve opens and closes to enable blood flow in one direction. However, in some circumstances the mitral valve is unable to close properly, allowing blood to regurgitate back into the atrium.


Mitral valve regurgitation has several causes. Functional mitral valve regurgitation is characterized by structurally normal mitral valve leaflets that are nevertheless unable to properly coapt with one another to close properly due to other structural deformations of surrounding heart structures. Other causes of mitral valve regurgitation are related to defects of the mitral valve leaflets, mitral valve annulus, or other mitral valve tissues.


The most common treatments for mitral valve regurgitation rely on valve replacement or repair including leaflet and annulus remodeling, the latter generally referred to as valve annuloplasty. One technique for mitral valve repair which relies on suturing adjacent segments of the opposed valve leaflets together is referred to as the “bowtie” or “edge-to-edge” technique. While all these techniques can be effective, they usually rely on open heart surgery where the patient's chest is opened, typically via a sternotomy, and the patient placed on cardiopulmonary bypass. The need to both open the chest and place the patient on bypass is traumatic and has associated high mortality and morbidity. In some patients, a fixation device can be installed into the heart using minimally invasive techniques. The fixation device can hold the adjacent segments of the opposed valve leaflets together and may reduce mitral valve regurgitation. One such device used to clip the anterior and posterior leaflets of the mitral valve together is the MitraClip® fixation device, sold by Abbott Vascular, Santa Clara, California, USA.


However, sometimes after a fixation device is installed, undesirable mitral valve regurgitation can still exist, or can arise again. For these sub-optimally treated patients, the presence of a fixation device in their mitral valves obstructs transcatheter mitral valve replacement. These patients may also be considered too frail to tolerate open-heart surgery, so they are left with no viable options to further improve the function of their mitral valve.


Accordingly, it would be desirable to provide alternative and additional methods, devices, and systems for removing or disabling fixation devices that are already installed. The methods, devices, and systems may be useful for repair of tissues in the body other than heart valves. At least some of these objectives will be met by the inventions described hereinbelow.


BRIEF SUMMARY OF THE INVENTION

Implementations of the present invention solve one or more problems in the art with systems, methods, and apparatus configured to cut leaflet tissue at a cardiac valve. A device may comprise a guide catheter having a proximal end and a distal end, the guide catheter being positionable at a cardiac valve. The device may further include a cutting mechanism routable through the guide catheter and configured to extend from the distal end of the guide catheter, the cutting mechanism configured to cut a portion of leaflet tissue of the cardiac valve. Finally, the device may comprise a handle coupled to the proximal end of the guide catheter, the handle comprising at least one control operatively connected to the cutting mechanism such that the at least one control is configured to provide selective actuation of the cutting mechanism.


A system for cutting leaflet tissue at a cardiac valve may comprise a guide catheter having a proximal end and a distal end, wherein the distal end of the guide catheter is guided to a position at a cardiac valve. The system may also comprise a cutting mechanism having a proximal end and a distal end, wherein the cutting mechanism is routable through the guide catheter and configured to extend beyond the distal end of the guide catheter and retract into the guide catheter, wherein the cutting mechanism is configured to cut a portion of leaflet tissue of the cardiac valve.


A method of cutting cardiac valve tissue at a cardiac valve within a body may comprise positioning a guide catheter, having a proximal and a distal end such that the distal end of the guide catheter is positioned at a cardiac valve. The method may also include routing a cutting mechanism through the guide catheter such that the cutting mechanism extends distally beyond the distal end of the guide catheter, wherein the cardiac valve is associated with an interventional implant that approximates adjacent leaflets of the cardiac valve, and a cutting mechanism extends from the guide catheter. Finally, the method may comprise actuating the cutting mechanism to cut at a portion of least one leaflet of the approximated adjacent leaflet.


Additional features and advantages of exemplary implementations of the invention will be set forth in the description which follows, and in part will be obvious from the description, or may be learned by the practice of such exemplary implementations. The features and advantages of such implementations may be realized and obtained by means of the instruments and combinations particularly pointed out in the appended claims. These and other features will become more fully apparent from the following description and appended claims or may be learned by the practice of such exemplary implementations as set forth hereinafter.





BRIEF DESCRIPTION OF THE DRAWINGS

In order to describe the manner in which the above-recited and other advantages and features of the invention can be obtained, a more particular description of the invention briefly described above will be rendered by reference to specific embodiments thereof which are illustrated in the appended drawings. Understanding that these drawings depict only typical embodiments of the invention and are not therefore to be considered to be limiting of its scope, the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIG. 1 illustrates an exemplary delivery system that may be utilized for guiding and/or delivering a cutting mechanism to a cardiac valve;



FIG. 2 is perspective view of an embodiment of a cutting mechanism according to the present disclosure shown in use in association with a human heart;



FIGS. 3A-3B illustrate a first embodiment of a cutting mechanism according to the present disclosure; and



FIGS. 4A-4C illustrate a second embodiment of a cutting mechanism according to the present disclosure.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Implementations of the present invention solve one or more problems in the art with systems, methods, and apparatus configured to cut leaflet tissue at a cardiac valve. More specifically, in at least one embodiment of the present invention a device may comprise a guide catheter having a proximal end and a distal end, the guide catheter being positionable at a cardiac valve. The device may further include a cutting mechanism routable through the guide catheter and configured to extend from the distal end of the guide catheter, the cutting mechanism configured to cut a portion of leaflet tissue of the cardiac valve. Finally, the device may comprise a handle coupled to the proximal end of the guide catheter, the handle comprising at least one control operatively connected to the cutting mechanism such that the at least one control is configured to provide selective actuation of the cutting mechanism.



FIG. 1 illustrates an exemplary embodiment of a leaflet cutting system 100, which can include a delivery system 102 that may be utilized for guiding and/or delivering a cutting mechanism to the cardiac valve. In at least one embodiment, the delivery system 102 can include a guide catheter 105 having a proximal end and a distal end 115. The delivery system may comprise a handle 110 positioned on the proximal end of the guide catheter 105. The guide catheter 105 may be operatively coupled to the handle 110. The guide catheter 105 may be steerable to enable the guiding and orienting of the guide catheter 105, including the distal end 115 of the guide catheter 105. For example, the handle 110 may include at least one control 120 (e.g., a dial, a switch, a slider, a button, etc.) that can be actuated to control the movement and curvature of the distal end 115 of the guide catheter 105.


In at least one embodiment, the at least one control 120 is operatively coupled to one or more control lines 125 (e.g., pull wires) extending from the handle 110 through the guide catheter 105 to the distal end 115 of the guide catheter (e.g., through one or more lumens in the guide catheter 105). Actuation of the at least one control 120 may adjust the tensioning of a control line 125 to pull the guide catheter 105 in the corresponding direction. FIG. 1 shows the handle 110 as having a single control 120 for providing steerability. Alternatively, a handle 110 may comprise more than one control 120 associated with any number of control lines. In at least one embodiment, the at least one control 120 can adjust four or more control lines 125 to selectively control directional movement and/or curvature of the steerable portion 117 of the guide catheter 105.


While control lines or wires are described at various points in this application, it should be understood that references made throughout this application to control lines or wires may be a single wire or a plurality of wires including, or made of, steel, titanium alloy, aluminum alloy, nickel alloy, other metals, a shape memory material (such as a shape memory alloy or shape memory polymer), inorganic polymer, organic polymer, ceramic, carbon materials, or other flexible material with sufficient tensile strength. For example, a control line 125 may be a steel cable. In another example, a control line 125 may be a monofilament suture. In another example, a control line 125 may be a multifilament suture. In yet another example, a control line 125 may be a braided suture.


It is desirable for guide catheter 105 to provide an adjustable distal end 115, which is capable of being positioned within a target body cavity in a desired orientation. Guide catheter 105 should have a large lumen diameter to accommodate the passage of a variety of devices, such as the various embodiments of the cutting mechanisms discussed hereinafter and should have good wall strength to avoid kinking or collapse when bent around tight curves, and should have good column, tensile, and torsional strength to avoid deformation when the devices are passed through the lumen and torqued or translated. Guide catheter 105 should provide for a high degree of controlled deflection at its distal end 115 but should not take up significant lumen area to allow for passage of interventional devices, such as the cutting mechanisms discussed below. Further, guide catheter 105 should be positionable in a manner which allows compound curves to be formed, for example curvature within more than one plane. Such manipulation should also allow fine control over distal end 115 to accommodate anatomical variations within the same type of body cavity and for use in different types of body cavities.


The guide catheter 105 may comprise a main body made of or including a flexible material. The main body may be made of or include a variety of flexible materials, such as thermoplastic elastomers (TPE). In some embodiments, the main body may be a polyether block amide (PEBA or PEBAX). The main body may have a constant durometer or may have varying durometer that varies along its longitudinal length or that varies in different portions of the body. For example, the main body of guide catheter 105 may be made of or include a body material having a durometer of 25 D to 75 D. In another example, the main body of guide catheter 105 may be made of or include a body material that has a durometer of about 45 D. In at least one embodiment, the body material may include PEBAX 4533. In at least another embodiment, the body material may include PEBAX 3533.


The guide catheter 105 preferably defines a central lumen, extending axially through its entire length, through which other elongate elements, such as the cutting mechanisms may be inserted for accessing a treatment site. The central lumen may also include a central lumen lining on an inner surface thereof. In some embodiments, the central lumen lining may be a protective material that protects the interior walls from damage due to another element of the elongated member moving through or within the central lumen. In other embodiments, the central lumen lining may include a lubricious coating that reduces friction between the interior wall and another element of the elongated member moving through or within the central lumen. The central lumen lining may include PEBA or PEBAX, polytetrafluoroethylene (“PTFE”), polyetheretherketone (“PEEK”), other polymers, thermoplastic polyurethane (“TPU”), polyethylene with pebble stone surface, silicone oil stainless steel, Nitinol, other metals, or combinations thereof. In at least one embodiment, the central lumen lining may include a plurality of PEBA or PEBAX materials having different durometers.


In other embodiments, the guide catheter 105 may also have an outer layer. In some embodiments, the outer layer may be made of or include a single material or may be made of or include different materials to impart different handling characteristics to the guide catheter 105. For example, the outer layer may be made of or include softer materials to promote flexibility of the guide catheter 105. In other examples, the outer layer may be made of or include stiffer materials to promote pushability and/or torqueability of the guide catheter 105. In yet other examples, the outer layer may include lubricious materials to reduce friction between the guide catheter 105 and the body lumen of the patient. The outer layer may include PEBA or PEBAX, polytetrafluoroethylene (“PTFE”), polyetheretherketone (“PEEK”), other polymers, thermoplastic polyurethane (“TPU”), polyethylene with pebble stone surface, silicone oil stainless steel, Nitinol, other metals, or combinations thereof. In at least one embodiment, the outer layer may include a plurality of PEBA or PEBAX materials having different durometers.


In some embodiments, the outer layer of guide catheter 105 may also include a radiopaque marker to improve visualization of guide catheter 105 during a medical procedure. For example, the outer layer may include a barium sulfate (BaSO4), gold, platinum, platinum iridium, iodine, other radiopaque materials, or combinations thereof on a distal portion of guide catheter 105. In at least one embodiment, one or more additional radiopaque markers may be longitudinally located at one or more intermediate locations along the length of guide catheter 105.


The curves of guide catheter 105 may be formed by any suitable means. In some embodiments, one or more of the curves are preset so that the curve is formed by shape memory. For example, guide catheter 105 may be comprised of a flexible polymer material in which a curve is preset by heating. When guide catheter 105 is loaded on a guidewire, dilator, obturator or introductory device, the flexibility of guide catheter 105 can allow it to follow the shape or path of the introductory device for proper positioning within the body. When the introductory device is pulled back and/or removed, guide catheter 105 can then resume the shape memory configuration which was preset into the catheter.


Alternatively, the curves may be formed or enhanced with the use of one or more steering mechanisms. In some embodiments, the steering mechanism comprises at least one control wire or pullwire attached to one of the guide catheter 105, wherein actuation of the steering mechanism applies tension to the at least one pullwire whereby the curve is formed. The pullwires can extend through the central lumen or through individual lumens in the wall of guide catheter 105. It may be appreciated that more than one pullwire may extend through any given lumen. The presence of each pullwire allows curvature of guide catheter 105 in the direction of the pullwire. For example, when pulling or applying tension to a pullwire extending along one side of the catheter, the catheter will bend, arc or form a curvature toward that side. To then straighten the catheter, the tension may be relieved for recoiling effects or tension may be applied to a pullwire extending along the opposite side of the catheter. Therefore, pullwires are often symmetrically placed along the sides of the catheter.


Thus, in some embodiments at least two pullwires are attached in diametrically opposed locations wherein applying tension to one of the pullwires curves the catheter in one direction and applying tension to the pullwire attached in the diametrically opposed location curves the catheter in another direction opposite to the one direction. The diametrically opposed pullwires may be considered a set. Any number of sets may be present in a catheter to provide unlimited directions of curvature. In some embodiments, the steering mechanism can comprise at least four pullwires wherein two of the at least four pullwires are attached to the guide catheter in diametrically opposed locations and another two of the at least four pullwires are attached to the guide catheter in diametrically opposed locations. In other words, the catheter may include two sets of pullwires, each set functioning in an opposing manner as described. When the two sets of pullwires are positioned so that each pullwire is 90 degrees apart, the catheter may be curved so that the distal end is directed from side to side and up and down. In other embodiments, the steering mechanism comprises at least three pullwires, each pullwire symmetrically positioned approximately 120 degrees apart. When tension is applied to any of the pullwires individually, the catheter is curved in the direction of the pullwire under tension. When tension is applied to two pullwires simultaneously, the catheter is curved in a direction between the pullwires under tension. Additional directions may also be achieved by various levels of tension on the pullwires. It may be appreciated that any number, combination and arrangement of pullwires may be used to direct the catheters in any desired direction.


In some embodiments, a portion of guide catheter 105 can comprise one or more articulating members. In this case, the at least one pullwire is attached to one of the articulating members so that the curve is formed by at least some of the articulating members. Each pullwire is attached to the catheter at a location chosen to result in a particular desired curvature of the catheter when tension is applied to the pullwire. For example, if a pullwire is attached to the most distal articulating member in the series, applying tension to the pullwire will compress the articulating members proximal to the attachment point along the path of the pullwire. This results in a curvature forming in the direction of the pullwire proximal to the attachment point. It may be appreciated that the pullwires may be attached to any location along the catheter and is not limited to attachment to articulating members. Typically, the articulating members comprise interfitting domed rings but may have any suitable shape.


It may also be appreciated that curves in guide catheter 105 may be formed by any combination of mechanisms. For example, a portion of guide catheter could form a curve by shape memory material, while a different portion of guide catheter could form a curve by actuation of a steering mechanism.


The steering mechanisms may be actuated by manipulation of actuators located on handle 110. The handle 110 can be connected with the proximal end of the guide catheter 105 and remains outside of the body. One or more actuators or controls 120 can be provided on handle 110 and may have any suitable form, including buttons, levers, knobs, switches, toggles, dials, or thumbwheels, to name a few. When pullwires are used, each actuator may apply tension to an individual pullwire or to a set of pullwires. The handle may also include one or more locking mechanisms (not shown in the figures) configured to interface with, and selectively lock into place, one or more of the controls 120.


In at least one embodiment, the handle 110 includes at least one control 120 for actuating and/or adjusting one or more components of a cutting mechanism 130. As shown in FIG. 1, the cutting mechanism 130 is configured to extend beyond the distal end 115 of the guide catheter 105. In at least one embodiment, the cutting mechanism 130 is routable through the guide catheter 105 and retractable into the guide catheter 105. The at least one control 120 may control the cutting mechanism's 130 extension from and retraction into the guide catheter 105. Additionally, or alternatively, the at least one control 120 may be configured to provide selective actuation of the cutting mechanism 130. The at least one control 120 may be operatively connected to one or more additional elements of the cutting mechanism 130. The cutting mechanism 130 is shown here in generic form as a dashed line, and therefore represents any of the cutting mechanism 130 embodiments described herein.



FIG. 2 is a perspective view of an exemplary embodiment of a cutting mechanism shown in use in association with a human heart, specifically the mitral valve 205. The mitral valve 205 comprises an anterior mitral leaflet 210 and a posterior mitral leaflet 215. FIG. 2 also shows an interventional implant (e.g., MitraClip®) 220, which has previously been affixed to the leaflets in an effort to reduce regurgitation. As shown, the affixation of implant 220 to the leaflets creates a first orifice 222 and a second orifice 224 located on opposing sides of implant 220 and between the anterior mitral leaflet 210 and the posterior mitral leaflet 215. And, as discussed above, if further treatment is required in the form of the installation of an artificial, replacement mitral valve, the prior clip implant 220 must be detached from one or both of the leaflets before the replacement valve can be implanted.


As further illustrated in FIG. 2, the distal end 115 of the guide catheter 105 can extend through an interatrial septum 200 of the heart. Once the distal end 115 of guide catheter 105 is properly positioned above the mitral valve 205, cutting mechanism 130 may be advanced to extend beyond the distal end 115 of guide catheter 110. In at least one embodiment, cutting mechanism 130 is configured to extend from the distal end 115 of the guide catheter 105 through the first orifice 222 of the mitral valve 205 (from an atrial side to a ventricle side), as shown in FIG. 2. One skilled in the art will appreciate that the positioning of the guide catheter 105 and cutting mechanism 130 in FIG. 2 is merely exemplary and the present invention is not limited to the positioning shown.



FIGS. 3A-3B illustrate a first embodiment of a cutting mechanism, designated as 130a. As shown, the cutting mechanism 130a may comprise an elongate inner catheter or shaft 300, extending from a proximal end (not shown in FIG. 3) to a distal end of the leaflet cutting system 100. The proximal end of the cutting mechanism 130a can be operatively coupled to the handle 110, and handle 110 provided with controls adapted to manipulate the cutting mechanism 130a, including advancing, retracting and/or rotating the cutting mechanism 130a relative to the guide catheter 105.


As shown in FIGS. 3A-3B, cutting mechanism 130a is positioned within the interior of guide catheter 105 during advancement and positioning of the system 100 above the mitral valve 205. As discussed below, once the distal end 115 of guide catheter 105 is properly positioned above the mitral valve 205 and in proper alignment with interventional implant 220, the handle 110 can be manipulated to cause cutting mechanism 130a to advance relative to guide catheter 105 and to pass through one of the orifices 222, 224 of the mitral valve 205, and then further manipulated to cause the cutting mechanism to slice through the tissue of one of the leaflets 210, 215, thereby cutting the affected leaflet and separating the interventional implant 220 from the affected leaflet.



FIG. 3A is a side perspective view showing the cutting mechanism 130a in use within a mitral valve 205 having an anterior mitral leaflet 210 and a posterior mitral leaflet 215. An interventional implant (e.g., MitraClip®) 220 approximates the adjacent leaflets 210 and 215. As shown in FIG. 3A, the cutting mechanism may comprise an inner catheter or shaft 300 having a proximal and distal end. The shaft 300 may be configured to extend from and retract into the distal end 115 of the guide catheter 105. In at least one embodiment the shaft 300 can comprise a hypotube. The distal end of the shaft 300 may comprise a stabilizing extension 302 configured to secure the interventional implant 220 when the shaft 300 is extended distally and the extension 302 engages with the mitral valve. The distal end of the shaft 300 may also comprise an opposing cutting edge 304 configured to cut a portion of leaflet tissue of the mitral valve. With the extension 302 in contact with the implant 220, shaft 300 can be rotated, thereby causing cutting edge 304 to cut an arcuate path through the leaflet tissue adjacent the implant 220 from first orifice 222 to second orifice 224. One skilled in the art will appreciate that the positioning in FIG. 3A is merely exemplary and the invention is not limited to the positioning shown.


The guide catheter is not shown in FIGS. 3A-3B, but it should be understood that cutting mechanism 130a is intended for use within a suitable guide catheter, such as that discussed above, to position the distal end of cutting mechanism 130a above the interventional device 220. Once properly positioned, shaft 300 can be advanced relative to the guide catheter so as to extend beyond the distal end of the guide catheter. With the shaft 300 advanced, the entire system can be advanced distally, until the distal end of stabilizing extension 302 engages the fold of leaflet tissue located opposite the interventional clip 220, which fold is created when the anterior and posterior leaflets 210 and 215 are brought and held together by interventional device 220. Once in that position, shaft 300 can be rotated to cause the cutting edge 304 to scribe an arc across the leaflet tissue from one orifice 222 to the other orifice 224, thereby cutting the leaflet tissue and separating the affected leaflet from the interventional device 220.


In at least one embodiment, the cutting mechanism 130 further comprises a wire (not shown) that extends from the handle 110 to the cutting edge 304, the wire configured to selectively provide electrosurgical energy to the portion of leaflet tissue of the mitral valve via the cutting edge 304. The cutting edge 304 may comprise a material with low impedance, such as platinum iridium, silver, gold, or a combination thereof. In at least one embodiment, the excision edge 304 comprises a sharp edge or other cutting means. Thus, cutting of the leaflet tissue by cutting edge 304 may be accomplished through mechanical cutting by cutting edge 304, by the application of electrosurgical energy through cutting edge 304, or by a combination of both.


Although FIG. 3A shows the cutting edge 304 positioned on the posterior mitral leaflet 215, in at least one embodiment the cutting mechanism 130a can be configured and/or utilized to cut a portion of anterior mitral leaflet 210. In either case, the interventional implant 220 may remain attached to the posterior mitral leaflet 210 thereby reducing the risk that the interventional implant 200 will interfere with functioning of the left ventricular outflow tract. Additionally, or alternatively, the posterior mitral leaflet 210 may be cut with little or acceptable risk of left ventricular outflow tract interference. In at least one embodiment, both leaflets can be cut and the interventional implant 200 removed from the patient via the leaflet cutting system 100.



FIG. 3B is a front perspective view of the cutting device 130a. As shown, the extension 302 extends distally past a distal end of the cutting edge 304. One skilled in the art will appreciate that the cutting mechanism 130a is not limited to that shown in FIGS. 3A-3B. Neither the extension 302 nor the cutting edge 304 is limited to the size or shape as illustrated.


In this and other embodiments described herein, inner catheter or hypotube 300 should preferably have sufficient flexibility as to be able to conform to bends formed by guide catheter 105. Additional flexibility to accommodate bending may be provided in certain regions of hypotube 300 by a series of laser cuts formed in the outer wall of hypotube 300. In addition, hypotube 300 should also provide sufficient compressive and tensile strength to permit forces to be transmitted through hypotube 300, from the proximal end to the distal end, sufficient to facilitate advancement and retraction of hypotube 300 relative to guide catheter 105 Further still, hypotube 300 should provide sufficient torqueability to allow a rotational force applied through one or more controls at the proximal end of system 100 to be transmitted through the length of hypotube 300 to facilitate rotation of hypotube 300 to effectuate cutting of leaflet tissue.



FIGS. 4A-4C illustrate a second embodiment of a cutting mechanism, designated as 130b. FIG. 4A is a side perspective view, and FIG. 4B is a front perspective view of the cutting mechanism 130b. Here, again, the guide catheter is not shown in FIGS. 4A-4B, but it should be understood that cutting mechanism 130b is intended for use within a suitable guide catheter, such as that discussed above, to position the distal end of cutting mechanism 130b above the interventional device 220.


As shown, the cutting mechanism 130b may comprise a shaft 400 having a proximal end and a distal end. The distal end of the shaft 400 can include a cutout area 402, with a cutting wire 404 that extends in an axial direction across the cutout 402. The height of cutout 402 should preferably be somewhat larger than the thickness of the leaflet tissue that is to be cut.


The shaft 400 may be configured to extend from the distal end 115 of the guide catheter 105. In at least one embodiment, the shaft 400 is configured to be selectively advanced beyond the distal end 115 of the guide catheter 105 into a first orifice 222 of the mitral valve 205. The guide catheter 105 may then be manipulated to move the shaft 400 in a transverse direction to bring cutting wire 404 into contact with leaflet tissue.


The cutting wire 404 may be configured to selectively provide electrosurgical energy to the portion of leaflet tissue of the mitral valve, thereby cutting the portion of leaflet tissue. In at least one embodiment, cutting wire 404 can comprise a material with low impedance, such as platinum iridium, silver, gold, or a combination thereof. Additionally, or alternatively, the cutting wire 404 can include a sharpened edge. The at least one control 120 may be configured to advance the shaft 400 along a horizontal plane, thereby cutting the portion of the leaflet tissue along the horizontal plane 406, as shown in FIG. 4C.


One skilled in the art will appreciate that the shaft 400, cutout area 402, and cutting wire 404 shown in FIGS. 4A-4B are merely exemplary, and the invention is not limited to the cutting mechanism 130b as illustrated. Further, although FIG. 4C illustrates the horizontal plane cutting path 406 on a portion of the anterior mitral leaflet 210, in at least one embodiment the posterior mitral leaflet 215 is cut. Further, the interventional implant 220 may be removed from the patient by cutting both leaflets 210 and 215.


One skilled in the art will appreciate that the present invention is not limited to use within the mitral valve. The cardiac valve could also be the tricuspid aortic, pulmonic valve, etc. More generally, the embodiments described herein may be applied in other implementations involving removal of a previously implanted or deployed device from tissue. Further, any suitable delivery approach may be used, including transseptal, transfemoral, radial, transjugular, or transapical.


In describing the various embodiments above, the description may at times have explicitly discussed one particular mitral valve leaflet, such as anterior leaflet 210. It should be understood and appreciated, however, that the invention is not intended to be limited to either specific leaflet, but instead can be used to cut either anterior leaflet 210, posterior leaflet 215, or both.


It should also be understood that the order of manipulation of components of the various embodiments as described above are provided as representative examples only, and changes in the order of manipulation that may be readily understood by those skilled in the art are intended to be encompassed within the scope of this disclosure.


Further still, in addition to the embodiments described above, it should also be understood that individual components from one embodiment could also be combined with and/or substituted for a comparable component described in a different embodiment.


Similarly, while many of the embodiments discussed above contemplate mechanical cutting of leaflet tissue by means of sharpened edges of a cutting element, it should be further understood that such embodiments could also be adapted to include suitable electrical connections between the cutting element and a source of electrosurgical energy so that such cutting elements may accomplish cutting of tissue by mechanical cutting, by the application of electrosurgical energy to surrounding tissue through the cutting element, or by a combination of both.


Also, with any or all of the foregoing embodiments, one or more components of the leaflet cutting system can also include one or more radiopaque and/or echogenic markers to aid in the visualization of such components during a procedure. For example, one or more radiopaque and/or echogenic markers can be provided on the distal end 115 and/or the steerable portion 117 of the guide catheter 105. Similarly, one or more radiopaque and/or echogenic markers can also be provided on various components of the different embodiments of the cutting mechanisms described above, including, but not limited to, such markings being provided on the distal ends of the inner catheter, hypotube, cutting blades, stabilizing extension, etc.


One skilled in the art will appreciate that the present invention is not limited to use within the mitral valve. The cardiac valve could also be the tricuspid aortic, pulmonic valve, etc. More generally, the embodiments described herein may be applied in other implementations involving removal of a previously implanted or deployed device from tissue. Further, although the figures show the guide catheter 105 extending through the interatrial septum 200, the present invention is not limited to use via a transseptal approach. Any suitable delivery approach may be used, including transfemoral, radial, transjugular, or transapical.


The present invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative and not restrictive. The scope of the invention is, therefore, indicated by the appended claims rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.


Following are some further example embodiments of the invention. These are presented only by way of example and are not intended to limit the scope of the invention in any way.


Embodiment 1. A device for cutting leaflet tissue at a cardiac valve, comprising: a guide catheter having a proximal end and a distal end, the guide catheter being positionable at a cardiac valve, a cutting mechanism routable through the guide catheter and configured to extend from the distal end of the guide catheter, the cutting mechanism configured to cut a portion of leaflet tissue of the cardiac valve, and a handle coupled to the proximal end of the guide catheter, the handle comprising at least one control operatively connected to the cutting mechanism such that the at least one control is configured to provide selective actuation of the cutting mechanism.


Embodiment 2. The device of embodiment 1, wherein the guide catheter is positionable at the cardiac valve transseptally or transapically.


Embodiment 3. The device in any of embodiments 1 to 2, wherein the cutting mechanism comprises an extension configured to secure an interventional implant and an opposing excision edge configured to cut the portion of leaflet tissue of the cardiac valve.


Embodiment 4. The device in any of embodiments 1-3, wherein the extension extends distally past a distal end of the excision edge.


Embodiment 5. The device in any of embodiments 1-4, wherein the cutting mechanism further comprises a wire that extends from the handle to the excision edge, the wire configured to selectively provide radio frequency current energy to the portion of leaflet tissue of the cardiac valve via the excision edge.


Embodiment 6. The device in any of embodiments 1-5, wherein the excision edge comprises a material with low impedance.


Embodiment 7. The device in any of embodiments 1-6, wherein the excision edge comprises platinum iridium, silver, gold, or a combination thereof.


Embodiment 8. The device in any of embodiments 1-7, wherein: the cutting mechanism comprises a shaft having a proximal end and a distal end, the cutting mechanism comprises a cutting wire disposed within the shaft, the distal end of the shaft comprises a cutout area that exposes a portion of the cutting wire disposed within the shaft, and the shaft is configured to extend from the distal end of the guide catheter through a first orifice of the cardiac valve thereby engaging the cutting wire with leaflet tissue.


Embodiment 9. The device in any of embodiments 1-8, wherein the cutting wire is configured to selectively provide radio frequency current energy to the portion of leaflet tissue of the cardiac valve thereby cutting the portion of leaflet tissue.


Embodiment 10. The device in any of embodiments 1-9, wherein the cutting wire comprises a material with low impedance.


Embodiment 11. The device in any of the embodiments 1-10, wherein the cutting wire comprises platinum iridium, silver, gold, or a combination thereof.


Embodiment 12. The device in any of embodiments 1-11, wherein the cutting wire comprises a sharp edge.


Embodiment 13. The device in any of embodiments 1-12, wherein the shaft is configured to advance along a horizontal plane thereby cutting the portion of the leaflet tissue along the horizontal plane.


Embodiment 14. A system for cutting leaflet tissue at a cardiac valve, comprising, a guide catheter having a proximal end and a distal end, wherein the distal end of the guide catheter is guided to a position at a cardiac valve; a cutting mechanism having a proximal end and a distal end, wherein the cutting mechanism is routable through the guide catheter and configured to extend beyond the distal end of the guide catheter and retract into the guide catheter, wherein the cutting mechanism is configured to cut a portion of leaflet tissue of the cardiac valve.


Embodiment 15. The system of embodiment 14, wherein the cutting mechanism comprises an extension configured to secure an interventional implant and an opposing excision edge configured to cut the portion of leaflet tissue of the cardiac valve.


Embodiment 16. The system in any of embodiments 14-15, wherein the extension extends distally past a distal end of the excision edge.


Embodiment 17. The system in any of embodiments 14-16, wherein the cutting mechanism further comprises a cutting wire that extends from the proximal end of the guide catheter to the excision edge, the cutting wire configured to selectively provide radio frequency current energy to the portion of leaflet tissue of the cardiac valve via the excision edge.


Embodiment 18. The system in any of embodiments 14-17, wherein: the cutting mechanism comprises a shaft having a proximal end and a distal end, the cutting mechanism comprises a cutting wire disposed within the shaft, the distal end of the shaft comprises a cutout area that exposes a portion of the wire disposed within the shaft, and the shaft is configured to extend from the distal end of the guide catheter through a first orifice of the cardiac valve thereby engaging the cutting wire with leaflet tissue.


Embodiment 19. The system in any of embodiments 14-18, wherein the cutting wire is configured to selectively provide radio frequency current energy to the portion of leaflet tissue of the cardiac valve thereby cutting the portion of leaflet tissue.


Embodiment 20. The system in any of embodiments 14-19, wherein the cutting wire comprises a sharp edge.


Embodiment 21. The system in any of embodiments 14-20, wherein the shaft is configured to advance along a horizontal plane thereby cutting the portion of the leaflet tissue along the horizontal plane.


Embodiment 22. A method of cutting cardiac valve tissue at a cardiac valve within a body, comprising: positioning a guide catheter, having a proximal and a distal end such that the distal end of the guide catheter is positioned at a cardiac valve, routing a cutting mechanism through the guide catheter such that the cutting mechanism extends distally beyond the distal end of the guide catheter, wherein the cardiac valve is associated with an interventional implant that approximates adjacent leaflets of the cardiac valve, and a cutting mechanism extends from the guide catheter, and actuating the cutting mechanism to cut at a portion of least one leaflet of the approximated adjacent leaflet.


Embodiment 23. The method of embodiment 22, wherein actuating the cutting mechanism comprises delivering radio frequency current energy through the cutting mechanism.

Claims
  • 1. A device for cutting leaflet tissue at a cardiac valve, comprising: a guide catheter having a proximal end and a distal end, the guide catheter being positionable at a cardiac valve;a cutting mechanism routable through the guide catheter and configured to extend from the distal end of the guide catheter, the cutting mechanism configured to cut a portion of leaflet tissue of the cardiac valve, wherein the cutting mechanism comprises: a stabilizing extension configured to make contact with an interventional implant, andan opposing excision edge configured to cut the portion of leaflet tissue of the cardiac valve, wherein the extension extends distally past a distal end of the excision edge, wherein the stabilizing extension provides an axis of rotation about which the opposing excision edge rotates to cut the portion of the leaflet tissue; anda handle coupled to the proximal end of the guide catheter, the handle comprising at least one control operatively connected to the cutting mechanism such that the at least one control is configured to provide selective actuation of the cutting mechanism.
  • 2. The device of claim 1, wherein the guide catheter is positionable at the cardiac valve transseptally or transapically.
  • 3. The device of claim 1, wherein the cutting mechanism further comprises: a shaft having a proximal end and a distal end;a cutting wire disposed within the shaft, wherein: the distal end of the shaft comprises a cutout area that exposes a portion of the cutting wire disposed within the shaft, andthe shaft is configured to extend from the distal end of the guide catheter through a first orifice of the cardiac valve thereby engaging the cutting wire with leaflet tissue.
  • 4. The device of claim 3, wherein the cutting wire comprises a sharpened edge.
  • 5. The device of claim 3, wherein the shaft is configured to advance along a horizontal plane thereby cutting the portion of the leaflet tissue along the horizontal plane.
  • 6. The device of claim 3, wherein the cutting wire is configured to selectively provide radio frequency current energy to the portion of leaflet tissue of the cardiac valve thereby cutting the portion of leaflet tissue.
  • 7. The device of claim 6, wherein the cutting wire comprises a material with low impedance.
  • 8. The device of claim 7, wherein the cutting wire comprises platinum iridium, silver, gold, or a combination thereof.
  • 9. The device of claim 1, wherein the cutting mechanism further comprises a wire that extends from the handle to the excision edge, the wire configured to selectively provide radio frequency current energy to the portion of leaflet tissue of the cardiac valve via the excision edge.
  • 10. The device of claim 9, wherein the excision edge comprises a material with low impedance.
  • 11. The device of claim 10, wherein the excision edge comprises platinum iridium, silver, gold, or a combination thereof.
  • 12. A system for cutting leaflet tissue at a cardiac valve, comprising, a guide catheter having a proximal end and a distal end, wherein the distal end of the guide catheter is guided to a position at a cardiac valve;a cutting mechanism having a proximal end and a distal end, wherein the cutting mechanism is routable through the guide catheter and configured to extend beyond the distal end of the guide catheter and retract into the guide catheter, wherein the cutting mechanism comprises: a shaft having a proximal end and a distal end;a cutout area formed in the distal end of the shaft;a cutting wire extending across the cutout area,wherein: the shaft is configured to extend from the distal end of the guide catheter through a first orifice of the cardiac valve thereby engaging the cutting wire with leaflet tissue,an extension configured to secure an interventional implant, andan opposing excision edge configured to cut the portion of leaflet tissue of the cardiac valve, wherein the extension extends distally past a distal end of the excision edge,wherein the cutting mechanism is configured to cut a portion of leaflet tissue of the cardiac valve.
  • 13. The system of claim 12, wherein the cutting mechanism further comprises a cutting wire that extends from the proximal end of the guide catheter to the excision edge, the cutting wire configured to selectively provide radio frequency current energy to the portion of leaflet tissue of the cardiac valve via the excision edge.
  • 14. The system of claim 12, wherein the cutting wire is configured to selectively provide radio frequency current energy to the portion of leaflet tissue of the cardiac valve thereby cutting the portion of leaflet tissue.
  • 15. The system of claim 12, wherein the wire comprises a sharpened edge.
  • 16. The system of claim 12, wherein the shaft is configured to advance along a horizontal plane thereby cutting the portion of the leaflet tissue along the horizontal plane.
  • 17. A method of cutting cardiac valve tissue at a cardiac valve within a body, comprising: positioning a guide catheter, having a proximal end and a distal end such that the distal end of the guide catheter is positioned at a cardiac valve;routing an electrosurgical cutting mechanism through the guide catheter such that the electrosurgical cutting mechanism extends distally beyond the distal end of the guide catheter, wherein the cardiac valve is associated with an interventional implant that approximates adjacent leaflets of the cardiac valve, and the electrosurgical cutting mechanism extends from the guide catheter, wherein the electrosurgical cutting mechanism comprises: a shaft having a proximal end and a distal end;a cutting wire disposed within the shaft, wherein: the distal end of the shaft comprises a cutout area that exposes a portion of the cutting wire disposed within the shaft, andthe shaft is configured to extend from the distal end of the guide catheter through a first orifice of the cardiac valve thereby engaging the cutting wire with leaflet tissue,an extension configured to secure an interventional implant, andan opposing excision edge configured to cut the portion of leaflet tissue of the cardiac valve, wherein the extension extends distally past a distal end of the excision edge; andactuating the cutting mechanism to cut at a portion of least one leaflet of the approximated adjacent leaflet,wherein the cutting wire provides electrosurgical energy to the portion of leaflet tissue via the opposing excision edge.
  • 18. The method of claim 17, wherein actuating the cutting mechanism comprises delivering radio frequency current energy through the cutting mechanism.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. Provisional Patent Application No. 63/020,671, filed May 6, 2020, the entire contents of which are incorporated by reference herein.

US Referenced Citations (703)
Number Name Date Kind
1996261 Storz Apr 1935 A
2097018 Chamberlin Oct 1937 A
2108206 Mecker Feb 1938 A
3296668 Aiken Jan 1967 A
3378010 Codling et al. Apr 1968 A
3470875 Johnson Oct 1969 A
3557780 Sato Jan 1971 A
3671979 Moulopoulos Jun 1972 A
3675639 Cimber Jul 1972 A
3776237 Hill et al. Dec 1973 A
3874338 Happel Apr 1975 A
3874388 King et al. Apr 1975 A
4007743 Blake Feb 1977 A
4056854 Boretos et al. Nov 1977 A
4064881 Meredith Dec 1977 A
4091815 Larsen May 1978 A
4112951 Hulka et al. Sep 1978 A
4235238 Ogiu et al. Nov 1980 A
4297749 Davis et al. Nov 1981 A
4312337 Donohue Jan 1982 A
4425908 Simon Jan 1984 A
4458682 Cerwin Jul 1984 A
4484579 Meno et al. Nov 1984 A
4487205 Di et al. Dec 1984 A
4498476 Cerwin et al. Feb 1985 A
4510934 Batra Apr 1985 A
4531522 Bedi et al. Jul 1985 A
4578061 Lemelson Mar 1986 A
4641366 Yokoyama et al. Feb 1987 A
4686965 Bonnet et al. Aug 1987 A
4777951 Cribier et al. Oct 1988 A
4809695 Gwathmey et al. Mar 1989 A
4872455 Pinchuk et al. Oct 1989 A
4878495 Grayzel Nov 1989 A
4917089 Sideris Apr 1990 A
4944295 Gwathmey et al. Jul 1990 A
4969890 Sugita et al. Nov 1990 A
4994077 Dobben Feb 1991 A
5015249 Nakao et al. May 1991 A
5019096 Fox et al. May 1991 A
5042707 Taheri Aug 1991 A
5047041 Samuels Sep 1991 A
5049153 Nakao et al. Sep 1991 A
5053043 Gottesman et al. Oct 1991 A
5061277 Carpentier et al. Oct 1991 A
5069679 Taheri Dec 1991 A
5071428 Chin et al. Dec 1991 A
5078722 Stevens Jan 1992 A
5078723 Dance et al. Jan 1992 A
5108368 Hammerslag et al. Apr 1992 A
5125758 Dewan Jun 1992 A
5171252 Friedland Dec 1992 A
5171259 Inoue Dec 1992 A
5190554 Coddington et al. Mar 1993 A
5195968 Lundquist et al. Mar 1993 A
5209756 Seedhom et al. May 1993 A
5217460 Knoepfler Jun 1993 A
5226429 Kuzmak Jul 1993 A
5226911 Chee et al. Jul 1993 A
5234437 Sepetka Aug 1993 A
5242456 Nash et al. Sep 1993 A
5250071 Palermo Oct 1993 A
5251611 Zehel et al. Oct 1993 A
5254130 Poncet et al. Oct 1993 A
5261916 Engelson Nov 1993 A
5271381 Ailinger et al. Dec 1993 A
5275578 Adams Jan 1994 A
5282845 Bush et al. Feb 1994 A
5304131 Paskar Apr 1994 A
5306283 Conners Apr 1994 A
5306286 Stack et al. Apr 1994 A
5312415 Palermo May 1994 A
5314424 Nicholas May 1994 A
5318525 West et al. Jun 1994 A
5320632 Heidmueller Jun 1994 A
5325845 Adair Jul 1994 A
5330442 Green et al. Jul 1994 A
5332402 Teitelbaum Jul 1994 A
5336227 Nakao et al. Aug 1994 A
5342393 Stack Aug 1994 A
5350397 Palermo et al. Sep 1994 A
5350399 Erlebacher et al. Sep 1994 A
5359994 Krauter et al. Nov 1994 A
5368564 Savage Nov 1994 A
5368601 Sauer et al. Nov 1994 A
5373854 Kolozsi Dec 1994 A
5383886 Kensey et al. Jan 1995 A
5387219 Rappe Feb 1995 A
5391182 Chin Feb 1995 A
5395030 Kuramoto et al. Mar 1995 A
5403312 Yates et al. Apr 1995 A
5403326 Harrison et al. Apr 1995 A
5411552 Andersen et al. May 1995 A
5417684 Jackson et al. May 1995 A
5417699 Klein et al. May 1995 A
5417700 Egan May 1995 A
5423830 Schneebaum et al. Jun 1995 A
5423857 Rosenman et al. Jun 1995 A
5423858 Bolanos et al. Jun 1995 A
5423882 Jackman et al. Jun 1995 A
5431666 Sauer et al. Jul 1995 A
5437551 Chalifoux Aug 1995 A
5437681 Meade et al. Aug 1995 A
5447966 Hermes et al. Sep 1995 A
5450860 O'Connor Sep 1995 A
5456400 Shichman et al. Oct 1995 A
5456684 Schmidt et al. Oct 1995 A
5462527 Stevens-Wright et al. Oct 1995 A
5472044 Hall et al. Dec 1995 A
5472423 Gronauer Dec 1995 A
5476470 Fitzgibbons, Jr. Dec 1995 A
5477856 Lundquist Dec 1995 A
5478309 Sweezer et al. Dec 1995 A
5478353 Yoon Dec 1995 A
5487746 Yu et al. Jan 1996 A
5496332 Sierra et al. Mar 1996 A
5507725 Savage et al. Apr 1996 A
5507755 Gresl et al. Apr 1996 A
5507757 Sauer et al. Apr 1996 A
5520701 Lerch May 1996 A
5522873 Jackman et al. Jun 1996 A
5527313 Scott et al. Jun 1996 A
5527321 Hinchliffe Jun 1996 A
5527322 Klein et al. Jun 1996 A
5536251 Evard et al. Jul 1996 A
5540705 Meade et al. Jul 1996 A
5542949 Yoon Aug 1996 A
5554185 Block et al. Sep 1996 A
5562678 Booker Oct 1996 A
5569274 Rapacki et al. Oct 1996 A
5571085 Accisano, III Nov 1996 A
5571137 Marlow et al. Nov 1996 A
5571215 Sterman et al. Nov 1996 A
5575802 McQuilkin et al. Nov 1996 A
5582611 Tsuruta et al. Dec 1996 A
5584803 Stevens et al. Dec 1996 A
5593424 Northrup, III Jan 1997 A
5593435 Carpentier et al. Jan 1997 A
5609598 Laufer et al. Mar 1997 A
5617854 Munsif Apr 1997 A
5618306 Roth et al. Apr 1997 A
5620452 Yoon Apr 1997 A
5620461 Muijs et al. Apr 1997 A
5626588 Sauer et al. May 1997 A
5634932 Schmidt Jun 1997 A
5636634 Kordis et al. Jun 1997 A
5639277 Mariant et al. Jun 1997 A
5640955 Ockuly et al. Jun 1997 A
5649937 Bito et al. Jul 1997 A
5662681 Nash et al. Sep 1997 A
5669917 Sauer et al. Sep 1997 A
5669919 Sanders et al. Sep 1997 A
5690671 Mcgurk et al. Nov 1997 A
5695504 Gifford et al. Dec 1997 A
5695505 Yoon Dec 1997 A
5702825 Keita et al. Dec 1997 A
5706824 Whittier Jan 1998 A
5709707 Lock et al. Jan 1998 A
5713910 Gordon et al. Feb 1998 A
5713911 Racenet et al. Feb 1998 A
5715817 Stevens-Wright et al. Feb 1998 A
5716367 Koike et al. Feb 1998 A
5718725 Sterman et al. Feb 1998 A
5719725 Nakao Feb 1998 A
5722421 Francese et al. Mar 1998 A
5725542 Yoon Mar 1998 A
5725556 Moser et al. Mar 1998 A
5738649 Macoviak Apr 1998 A
5741271 Nakao et al. Apr 1998 A
5741280 Fleenor Apr 1998 A
5746747 Mckeating May 1998 A
5749828 Yeung May 1998 A
5759193 Burbank et al. Jun 1998 A
5769812 Stevens et al. Jun 1998 A
5769863 Garrison Jun 1998 A
5772578 Heimberger et al. Jun 1998 A
5782845 Shewchuk Jul 1998 A
5797927 Yoon Aug 1998 A
5797960 Stevens et al. Aug 1998 A
5810847 Laufer et al. Sep 1998 A
5810849 Kontos Sep 1998 A
5810853 Yoon Sep 1998 A
5810876 Kelleher Sep 1998 A
5814029 Hassett Sep 1998 A
5820591 Thompson et al. Oct 1998 A
5820592 Hammerslag Oct 1998 A
5820630 Lind Oct 1998 A
5820631 Nobles Oct 1998 A
5823955 Kuck et al. Oct 1998 A
5823956 Roth et al. Oct 1998 A
5824065 Gross Oct 1998 A
5827237 Macoviak et al. Oct 1998 A
5829447 Stevens et al. Nov 1998 A
5833671 Macoviak et al. Nov 1998 A
5836955 Buelna et al. Nov 1998 A
5840081 Andersen et al. Nov 1998 A
5843031 Hermann et al. Dec 1998 A
5843103 Wulfman Dec 1998 A
5849019 Yoon Dec 1998 A
5853422 Huebsch et al. Dec 1998 A
5855271 Eubanks et al. Jan 1999 A
5855590 Malecki et al. Jan 1999 A
5855614 Stevens et al. Jan 1999 A
5860990 Nobles et al. Jan 1999 A
5861003 Latson et al. Jan 1999 A
5868733 Ockuly et al. Feb 1999 A
5876399 Chia et al. Mar 1999 A
5879307 Chio et al. Mar 1999 A
5885271 Hamilton et al. Mar 1999 A
5891160 Williamson et al. Apr 1999 A
5895404 Ruiz Apr 1999 A
5895417 Pomeranz et al. Apr 1999 A
5906620 Nakao et al. May 1999 A
5908420 Parins et al. Jun 1999 A
5916147 Boury Jun 1999 A
5928224 Laufer Jul 1999 A
5944733 Engelson Aug 1999 A
5947363 Bolduc et al. Sep 1999 A
5954732 Hart et al. Sep 1999 A
5957949 Leonhardt et al. Sep 1999 A
5957973 Quiachon et al. Sep 1999 A
5972020 Carpentier et al. Oct 1999 A
5972030 Garrison et al. Oct 1999 A
5980455 Daniel et al. Nov 1999 A
5989284 Laufer Nov 1999 A
5997547 Nakao et al. Dec 1999 A
6007546 Snow et al. Dec 1999 A
6015417 Reynolds, Jr. Jan 2000 A
6019722 Spence et al. Feb 2000 A
6022360 Reimels et al. Feb 2000 A
6033378 Lundquist et al. Mar 2000 A
6033419 Hamblin et al. Mar 2000 A
6036699 Andreas et al. Mar 2000 A
6048351 Gordon et al. Apr 2000 A
6053933 Balazs et al. Apr 2000 A
6056769 Epstein et al. May 2000 A
6059757 Macoviak et al. May 2000 A
6060628 Aoyama et al. May 2000 A
6060629 Pham et al. May 2000 A
6063106 Gibson May 2000 A
6066146 Carroll et al. May 2000 A
6068628 Fanton et al. May 2000 A
6068629 Haissaguerre et al. May 2000 A
6077214 Mortier et al. Jun 2000 A
6086600 Kortenbach Jul 2000 A
6088889 Luther et al. Jul 2000 A
6090118 McGuckin, Jr. Jul 2000 A
6099505 Ryan et al. Aug 2000 A
6099553 Hart et al. Aug 2000 A
6110145 Macoviak Aug 2000 A
6117144 Nobles et al. Sep 2000 A
6117159 Huebsch et al. Sep 2000 A
6123665 Kawano Sep 2000 A
6123699 Webster, Jr. Sep 2000 A
6126658 Baker Oct 2000 A
6132447 Dorsey Oct 2000 A
6136010 Modesitt et al. Oct 2000 A
6139508 Simpson et al. Oct 2000 A
6143024 Campbell et al. Nov 2000 A
6159240 Sparer et al. Dec 2000 A
6162233 Williamson et al. Dec 2000 A
6165164 Hill et al. Dec 2000 A
6165183 Kuehn et al. Dec 2000 A
6165204 Levinson et al. Dec 2000 A
6168614 Andersen et al. Jan 2001 B1
6171320 Monassevitch Jan 2001 B1
6174322 Schneidt Jan 2001 B1
6180059 Divino et al. Jan 2001 B1
6182664 Cosgrove Feb 2001 B1
6187003 Buysse et al. Feb 2001 B1
6190408 Melvin Feb 2001 B1
6197043 Davidson Mar 2001 B1
6203531 Ockuly et al. Mar 2001 B1
6203553 Robertson et al. Mar 2001 B1
6206893 Klein et al. Mar 2001 B1
6206907 Marino et al. Mar 2001 B1
6210419 Mayenberger et al. Apr 2001 B1
6210432 Solem et al. Apr 2001 B1
6245079 Nobles et al. Jun 2001 B1
6264617 Bales et al. Jul 2001 B1
6267746 Bumbalough Jul 2001 B1
6267781 Tu Jul 2001 B1
6269819 Oz et al. Aug 2001 B1
6277555 Duran et al. Aug 2001 B1
6283127 Sterman et al. Sep 2001 B1
6283962 Tu et al. Sep 2001 B1
6299637 Shaolian et al. Oct 2001 B1
6306133 Tu et al. Oct 2001 B1
6312447 Grimes Nov 2001 B1
6319250 Falwell et al. Nov 2001 B1
6322559 Daulton et al. Nov 2001 B1
6332893 Mortier et al. Dec 2001 B1
6334860 Dorn Jan 2002 B1
6352708 Duran et al. Mar 2002 B1
6355030 Aldrich et al. Mar 2002 B1
6358277 Duran Mar 2002 B1
6368326 Dakin et al. Apr 2002 B1
6387104 Pugsley et al. May 2002 B1
6402780 Williamson et al. Jun 2002 B2
6402781 Langberg et al. Jun 2002 B1
6406420 McCarthy et al. Jun 2002 B1
6419640 Taylor Jul 2002 B1
6419669 Frazier et al. Jul 2002 B1
6461366 Seguin Oct 2002 B1
6464707 Bjerken Oct 2002 B1
6482224 Michler et al. Nov 2002 B1
6485489 Teirstein et al. Nov 2002 B2
6494881 Bales et al. Dec 2002 B1
6508828 Akerfeldt et al. Jan 2003 B1
6517550 Konya et al. Feb 2003 B1
6533796 Sauer et al. Mar 2003 B1
6537314 Langberg et al. Mar 2003 B2
6540755 Ockuly et al. Apr 2003 B2
6551331 Nobles et al. Apr 2003 B2
6562037 Paton et al. May 2003 B2
6562052 Nobles et al. May 2003 B2
6575971 Hauck et al. Jun 2003 B2
6585761 Taheri Jul 2003 B2
6599311 Biggs et al. Jul 2003 B1
6616684 Vidlund et al. Sep 2003 B1
6619291 Hlavka et al. Sep 2003 B2
6626899 Houser et al. Sep 2003 B2
6626921 Blatter et al. Sep 2003 B2
6626930 Allen et al. Sep 2003 B1
6629534 St et al. Oct 2003 B1
6641592 Sauer et al. Nov 2003 B1
6656221 Taylor et al. Dec 2003 B2
6669687 Saadat Dec 2003 B1
6685648 Flaherty et al. Feb 2004 B2
6689164 Seguin Feb 2004 B1
6695866 Kuehn et al. Feb 2004 B1
6701929 Hussein Mar 2004 B2
6702825 Frazier et al. Mar 2004 B2
6702826 Liddicoat et al. Mar 2004 B2
6709382 Horner Mar 2004 B1
6709456 Langberg et al. Mar 2004 B2
6718985 Hlavka et al. Apr 2004 B2
6719767 Kimblad Apr 2004 B1
6723038 Schroeder et al. Apr 2004 B1
6726716 Marquez Apr 2004 B2
6740107 Loeb et al. May 2004 B2
6746471 Mortier et al. Jun 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6755777 Schweich et al. Jun 2004 B2
6764510 Vidlund et al. Jul 2004 B2
6767349 Ouchi Jul 2004 B2
6770083 Seguin Aug 2004 B2
6797001 Mathis et al. Sep 2004 B2
6797002 Spence et al. Sep 2004 B2
6860179 Hopper et al. Mar 2005 B2
6875224 Grimes Apr 2005 B2
6926715 Hauck et al. Aug 2005 B1
6932810 Ryan Aug 2005 B2
6945978 Hyde Sep 2005 B1
6949122 Adams et al. Sep 2005 B2
6966914 Abe Nov 2005 B2
6986775 Morales et al. Jan 2006 B2
7004970 Cauthen et al. Feb 2006 B2
7011669 Kimblad Mar 2006 B2
7033390 Johnson et al. Apr 2006 B2
7048754 Martin et al. May 2006 B2
7056294 Khairkhahan et al. Jun 2006 B2
7112207 Allen et al. Sep 2006 B2
7226467 Lucatero Jun 2007 B2
7258694 Choi et al. Aug 2007 B1
7288097 Seguin Oct 2007 B2
7291168 Macoviak et al. Nov 2007 B2
7338467 Lutter Mar 2008 B2
7381210 Zarbatany et al. Jun 2008 B2
7435257 Lashinski et al. Oct 2008 B2
7464712 Oz et al. Dec 2008 B2
7497822 Kugler et al. Mar 2009 B1
7533790 Knodel et al. May 2009 B1
7563267 Goldfarb et al. Jul 2009 B2
7563273 Goldfarb et al. Jul 2009 B2
7604646 Goldfarb et al. Oct 2009 B2
7608091 Goldfarb et al. Oct 2009 B2
7635329 Goldfarb et al. Dec 2009 B2
7651502 Jackson Jan 2010 B2
7655015 Goldfarb et al. Feb 2010 B2
7666204 Thornton et al. Feb 2010 B2
7955340 Michlitsch et al. Jun 2011 B2
8216234 Long Jul 2012 B2
8257356 Bleich et al. Sep 2012 B2
8398708 Meiri et al. Mar 2013 B2
8435237 Bahney May 2013 B2
8496655 Epp et al. Jul 2013 B2
8500768 Cohen Aug 2013 B2
8523881 Cabiri et al. Sep 2013 B2
8623077 Cohn Jan 2014 B2
8690858 Machold et al. Apr 2014 B2
8821518 Saliman et al. Sep 2014 B2
8926588 Berthiaume et al. Jan 2015 B2
9126032 Khairkhahan et al. Sep 2015 B2
9211119 Hendricksen et al. Dec 2015 B2
9370341 Ceniccola et al. Jun 2016 B2
9498331 Chang et al. Nov 2016 B2
9572666 Basude et al. Feb 2017 B2
9770256 Cohen et al. Sep 2017 B2
9949833 McCleary et al. Apr 2018 B2
10238493 Metchik et al. Mar 2019 B1
10667804 Basude et al. Jun 2020 B2
11013554 Coates May 2021 B2
11406250 Saadat et al. Aug 2022 B2
20010002445 Vesely May 2001 A1
20010004715 Duran et al. Jun 2001 A1
20010005787 Oz et al. Jun 2001 A1
20010010005 Kammerer et al. Jul 2001 A1
20010018611 Solem et al. Aug 2001 A1
20010022872 Marui Sep 2001 A1
20010037084 Nardeo Nov 2001 A1
20010039411 Johansson et al. Nov 2001 A1
20010044568 Langberg et al. Nov 2001 A1
20010044635 Niizeki et al. Nov 2001 A1
20020013547 Paskar Jan 2002 A1
20020013571 Goldfarb et al. Jan 2002 A1
20020022848 Garrison et al. Feb 2002 A1
20020026233 Shaknovich Feb 2002 A1
20020035361 Houser et al. Mar 2002 A1
20020035381 Bardy et al. Mar 2002 A1
20020042651 Liddicoat et al. Apr 2002 A1
20020055767 Forde et al. May 2002 A1
20020055774 Liddicoat May 2002 A1
20020055775 Carpentier et al. May 2002 A1
20020058910 Hermann et al. May 2002 A1
20020058995 Stevens May 2002 A1
20020077687 Ahn Jun 2002 A1
20020087148 Brock et al. Jul 2002 A1
20020087169 Brock et al. Jul 2002 A1
20020087173 Alferness et al. Jul 2002 A1
20020103532 Langberg et al. Aug 2002 A1
20020107534 Schaefer et al. Aug 2002 A1
20020147456 Diduch et al. Oct 2002 A1
20020156526 Hlavka et al. Oct 2002 A1
20020158528 Tsuzaki et al. Oct 2002 A1
20020161378 Downing Oct 2002 A1
20020169360 Taylor et al. Nov 2002 A1
20020173811 Tu et al. Nov 2002 A1
20020173841 Ortiz et al. Nov 2002 A1
20020183766 Seguin Dec 2002 A1
20020183787 Wahr et al. Dec 2002 A1
20020183835 Taylor et al. Dec 2002 A1
20030005797 Hopper et al. Jan 2003 A1
20030045778 Ohline et al. Mar 2003 A1
20030050693 Quijano et al. Mar 2003 A1
20030069570 Witzel et al. Apr 2003 A1
20030069593 Tremulis et al. Apr 2003 A1
20030069636 Solem et al. Apr 2003 A1
20030074012 Nguyen et al. Apr 2003 A1
20030078654 Taylor et al. Apr 2003 A1
20030083742 Spence et al. May 2003 A1
20030105519 Fasol et al. Jun 2003 A1
20030105520 Alferness et al. Jun 2003 A1
20030120340 Liska et al. Jun 2003 A1
20030120341 Shennib et al. Jun 2003 A1
20030130669 Damarati Jul 2003 A1
20030130730 Cohn et al. Jul 2003 A1
20030144697 Mathis et al. Jul 2003 A1
20030167071 Martin et al. Sep 2003 A1
20030171776 Adams et al. Sep 2003 A1
20030187467 Schreck Oct 2003 A1
20030195562 Collier et al. Oct 2003 A1
20030208231 Williamson et al. Nov 2003 A1
20030229395 Cox Dec 2003 A1
20030233038 Hassett Dec 2003 A1
20040002719 Oz et al. Jan 2004 A1
20040003819 St et al. Jan 2004 A1
20040015232 Shu et al. Jan 2004 A1
20040019377 Taylor et al. Jan 2004 A1
20040019378 Hlavka et al. Jan 2004 A1
20040024414 Downing Feb 2004 A1
20040030319 Korkor et al. Feb 2004 A1
20040030382 St et al. Feb 2004 A1
20040034380 Woolfson et al. Feb 2004 A1
20040039442 St et al. Feb 2004 A1
20040039443 Solem et al. Feb 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040044365 Bachman Mar 2004 A1
20040049207 Goldfarb et al. Mar 2004 A1
20040049211 Tremulis et al. Mar 2004 A1
20040059345 Nakao et al. Mar 2004 A1
20040073302 Rourke et al. Apr 2004 A1
20040078053 Berg et al. Apr 2004 A1
20040087975 Lucatero et al. May 2004 A1
20040088047 Spence et al. May 2004 A1
20040092858 Wilson et al. May 2004 A1
20040092962 Thornton et al. May 2004 A1
20040097878 Anderson et al. May 2004 A1
20040097979 Svanidze et al. May 2004 A1
20040106989 Wilson et al. Jun 2004 A1
20040111099 Nguyen et al. Jun 2004 A1
20040116848 Gardeski et al. Jun 2004 A1
20040116951 Rosengart Jun 2004 A1
20040122448 Levine Jun 2004 A1
20040127849 Kantor Jul 2004 A1
20040127981 Rahdert et al. Jul 2004 A1
20040127982 Machold et al. Jul 2004 A1
20040127983 Mortier et al. Jul 2004 A1
20040133062 Pai et al. Jul 2004 A1
20040133063 McCarthy et al. Jul 2004 A1
20040133082 Abraham-Fuchs et al. Jul 2004 A1
20040133192 Houser et al. Jul 2004 A1
20040133220 Lashinski et al. Jul 2004 A1
20040133232 Rosenbluth et al. Jul 2004 A1
20040133240 Adams et al. Jul 2004 A1
20040133273 Cox Jul 2004 A1
20040138744 Lashinski et al. Jul 2004 A1
20040138745 Macoviak et al. Jul 2004 A1
20040147826 Peterson Jul 2004 A1
20040148021 Cartledge et al. Jul 2004 A1
20040152847 Emri et al. Aug 2004 A1
20040152947 Schroeder et al. Aug 2004 A1
20040153144 Seguin Aug 2004 A1
20040158123 Jayaraman Aug 2004 A1
20040162610 Liska et al. Aug 2004 A1
20040167539 Kuehn et al. Aug 2004 A1
20040186486 Roue et al. Sep 2004 A1
20040186566 Hindrichs et al. Sep 2004 A1
20040193191 Starksen et al. Sep 2004 A1
20040215339 Drasler et al. Oct 2004 A1
20040220593 Greenhalgh Nov 2004 A1
20040220657 Nieminen et al. Nov 2004 A1
20040225233 Frankowski et al. Nov 2004 A1
20040225300 Goldfarb et al. Nov 2004 A1
20040225305 Ewers et al. Nov 2004 A1
20040225353 McGuckin et al. Nov 2004 A1
20040236354 Seguin Nov 2004 A1
20040242960 Orban Dec 2004 A1
20040243229 Vidlund et al. Dec 2004 A1
20040249452 Adams et al. Dec 2004 A1
20040249453 Cartledge et al. Dec 2004 A1
20040260393 Rahdert et al. Dec 2004 A1
20050004583 Oz et al. Jan 2005 A1
20050004665 Aklog Jan 2005 A1
20050004668 Aklog et al. Jan 2005 A1
20050021056 St et al. Jan 2005 A1
20050021057 St et al. Jan 2005 A1
20050021058 Negro Jan 2005 A1
20050033446 Deem et al. Feb 2005 A1
20050038383 Kelley et al. Feb 2005 A1
20050038508 Gabbay Feb 2005 A1
20050049698 Bolling et al. Mar 2005 A1
20050055089 Macoviak et al. Mar 2005 A1
20050059351 Cauwels et al. Mar 2005 A1
20050065453 Shabaz et al. Mar 2005 A1
20050085903 Lau Apr 2005 A1
20050119735 Spence et al. Jun 2005 A1
20050131438 Cohn Jun 2005 A1
20050143809 Salahieh et al. Jun 2005 A1
20050149014 Hauck et al. Jul 2005 A1
20050159763 Mollenauer et al. Jul 2005 A1
20050159810 Filsoufi Jul 2005 A1
20050192633 Montpetit Sep 2005 A1
20050197694 Pai et al. Sep 2005 A1
20050197695 Stacchino et al. Sep 2005 A1
20050216039 Lederman Sep 2005 A1
20050228422 Machold et al. Oct 2005 A1
20050228495 Macoviak Oct 2005 A1
20050251001 Hassett Nov 2005 A1
20050256452 Demarchi et al. Nov 2005 A1
20050267493 Schreck et al. Dec 2005 A1
20050273160 Lashinski et al. Dec 2005 A1
20050277876 Hayden Dec 2005 A1
20050287493 Novak et al. Dec 2005 A1
20060004247 Kute et al. Jan 2006 A1
20060009759 Chrisitian Jan 2006 A1
20060015003 Moaddes et al. Jan 2006 A1
20060015179 Bulman-Fleming et al. Jan 2006 A1
20060020275 Goldfarb et al. Jan 2006 A1
20060020327 Lashinski et al. Jan 2006 A1
20060020334 Lashinski et al. Jan 2006 A1
20060030866 Schreck Feb 2006 A1
20060030867 Zadno Feb 2006 A1
20060030885 Hyde Feb 2006 A1
20060058871 Zakay et al. Mar 2006 A1
20060064115 Allen et al. Mar 2006 A1
20060064116 Allen et al. Mar 2006 A1
20060064118 Kimblad Mar 2006 A1
20060074484 Huber Apr 2006 A1
20060089671 Goldfarb et al. Apr 2006 A1
20060089711 Dolan Apr 2006 A1
20060135961 Rosenman et al. Jun 2006 A1
20060135993 Seguin Jun 2006 A1
20060184198 Bales et al. Aug 2006 A1
20060184203 Martin et al. Aug 2006 A1
20060195012 Mortier et al. Aug 2006 A1
20060229708 Powell et al. Oct 2006 A1
20060252984 Rahdert et al. Nov 2006 A1
20060276890 Solem et al. Dec 2006 A1
20070016225 Nakao Jan 2007 A1
20070038293 St et al. Feb 2007 A1
20070060997 de Boer Mar 2007 A1
20070073185 Nakao Mar 2007 A1
20070100356 Lucatero et al. May 2007 A1
20070118155 Goldfarb et al. May 2007 A1
20070129737 Goldfarb et al. Jun 2007 A1
20070173757 Levine et al. Jul 2007 A1
20070197858 Goldfarb et al. Aug 2007 A1
20070198082 Kapadia et al. Aug 2007 A1
20070260225 Sakakine et al. Nov 2007 A1
20070287884 Schena Dec 2007 A1
20080009858 Rizvi Jan 2008 A1
20080039935 Buch et al. Feb 2008 A1
20080045936 Vaska et al. Feb 2008 A1
20080051703 Thornton et al. Feb 2008 A1
20080051807 St et al. Feb 2008 A1
20080097467 Gruber et al. Apr 2008 A1
20080097489 Goldfarb et al. Apr 2008 A1
20080167714 St et al. Jul 2008 A1
20080183194 Goldfarb et al. Jul 2008 A1
20080188850 Mody et al. Aug 2008 A1
20080195126 Solem Aug 2008 A1
20080243249 Kohm et al. Oct 2008 A1
20080294175 Bardsley et al. Nov 2008 A1
20080312496 Zwolinski Dec 2008 A1
20090012538 Saliman et al. Jan 2009 A1
20090036768 Seehusen et al. Feb 2009 A1
20090156995 Martin et al. Jun 2009 A1
20090163934 Raschdorf et al. Jun 2009 A1
20090177266 Powell et al. Jul 2009 A1
20090192510 Bahney Jul 2009 A1
20090198322 Deem et al. Aug 2009 A1
20090204005 Keast et al. Aug 2009 A1
20090209955 Forster et al. Aug 2009 A1
20090209991 Hinchliffe et al. Aug 2009 A1
20090270858 Hauck et al. Oct 2009 A1
20090276039 Meretei Nov 2009 A1
20090281619 Le et al. Nov 2009 A1
20090326567 Goldfarb et al. Dec 2009 A1
20100016958 St et al. Jan 2010 A1
20100022823 Goldfarb et al. Jan 2010 A1
20100044410 Argentine et al. Feb 2010 A1
20100121437 Subramanian et al. May 2010 A1
20100152612 Headley et al. Jun 2010 A1
20100217261 Watson Aug 2010 A1
20100262231 Tuval et al. Oct 2010 A1
20100268226 Epp et al. Oct 2010 A1
20100298929 Thornton et al. Nov 2010 A1
20110009864 Bucciaglia et al. Jan 2011 A1
20110184405 Mueller Jul 2011 A1
20110224710 Bleich Sep 2011 A1
20110238052 Robinson Sep 2011 A1
20110282250 Fung et al. Nov 2011 A1
20120022527 Woodruff et al. Jan 2012 A1
20120022640 Gross et al. Jan 2012 A1
20120065464 Ellis et al. Mar 2012 A1
20120150194 Odermatt et al. Jun 2012 A1
20120157765 Mitelberg Jun 2012 A1
20120172915 Fifer et al. Jul 2012 A1
20120179184 Orlov Jul 2012 A1
20120265222 Gordin et al. Oct 2012 A1
20120310330 Buchbinder et al. Dec 2012 A1
20120316639 Kleinschrodt Dec 2012 A1
20120330348 Strauss et al. Dec 2012 A1
20130041314 Dillon Feb 2013 A1
20130066341 Ketai et al. Mar 2013 A1
20130066342 Dell et al. Mar 2013 A1
20130109910 Alexander et al. May 2013 A1
20130172828 Kappel et al. Jul 2013 A1
20130317515 Kuroda et al. Nov 2013 A1
20140039511 Morris et al. Feb 2014 A1
20140135799 Henderson May 2014 A1
20140228871 Cohen et al. Aug 2014 A1
20140276913 Tah Sep 2014 A1
20140309670 Bakos et al. Oct 2014 A1
20140324164 Gross et al. Oct 2014 A1
20140350662 Vaturi Nov 2014 A1
20140358224 Tegels et al. Dec 2014 A1
20140364866 Dryden et al. Dec 2014 A1
20140379074 Spence et al. Dec 2014 A1
20150005704 Heisel et al. Jan 2015 A1
20150005801 Marquis et al. Jan 2015 A1
20150051698 Ruyra et al. Feb 2015 A1
20150094800 Chawla Apr 2015 A1
20150112430 Creaven et al. Apr 2015 A1
20150211946 Pons et al. Jul 2015 A1
20150230947 Krieger et al. Aug 2015 A1
20150257877 Hernandez Sep 2015 A1
20150257883 Basude et al. Sep 2015 A1
20150306806 Dando et al. Oct 2015 A1
20150313581 Wolfe et al. Nov 2015 A1
20160015410 Asirvatham et al. Jan 2016 A1
20160074165 Spence et al. Mar 2016 A1
20160174979 Wei Jun 2016 A1
20160317174 Dake Nov 2016 A1
20170042678 Ganesan et al. Feb 2017 A1
20170100183 Iaizzo et al. Apr 2017 A1
20170143330 Basude et al. May 2017 A1
20170202559 Taha Jul 2017 A1
20170232238 Biller et al. Aug 2017 A1
20180008268 Khairkhahan Jan 2018 A1
20180028215 Cohen Feb 2018 A1
20180092661 Prabhu Apr 2018 A1
20180133010 Kizuka May 2018 A1
20180161159 Lee et al. Jun 2018 A1
20180360457 Ellis et al. Dec 2018 A1
20190029790 Bak-Boychuk et al. Jan 2019 A1
20190183571 De Marchena Jun 2019 A1
20190298517 Sanchez et al. Oct 2019 A1
20190307458 Mathis et al. Oct 2019 A1
20200121460 Dale et al. Apr 2020 A1
20210113232 Ortiz et al. Apr 2021 A1
20210145574 Childs May 2021 A1
Foreign Referenced Citations (163)
Number Date Country
1469724 Jan 2004 CN
102770080 Nov 2012 CN
103841899 Jun 2014 CN
104244841 Dec 2014 CN
3504292 Jul 1986 DE
9100873 Apr 1991 DE
10116168 Nov 2001 DE
0179562 Apr 1986 EP
0558031 Sep 1993 EP
0684012 Nov 1995 EP
0727239 Aug 1996 EP
0782836 Jul 1997 EP
1230899 Aug 2002 EP
1674040 Jun 2006 EP
1980288 Oct 2008 EP
2005912 Dec 2008 EP
2537487 Dec 2012 EP
2641570 Sep 2013 EP
2702965 Mar 2014 EP
2740419 Jun 2014 EP
3009103 Apr 2016 EP
2705556 Dec 1994 FR
2768324 Mar 1999 FR
2903292 Jan 2008 FR
1598111 Sep 1981 GB
2151142 Jul 1985 GB
09-253030 Sep 1997 JP
11-089937 Apr 1999 JP
2000-283130 Oct 2000 JP
2001-517529 Oct 2001 JP
2006-528911 Dec 2006 JP
2013-516244 May 2013 JP
2013-523384 Jun 2013 JP
2014-523274 Sep 2014 JP
2015-502548 Jan 2015 JP
2018-030008 Mar 2018 JP
8100668 Mar 1981 WO
9101689 Feb 1991 WO
9118881 Dec 1991 WO
9212690 Aug 1992 WO
9418881 Sep 1994 WO
9418893 Sep 1994 WO
9508292 Mar 1995 WO
9511620 May 1995 WO
9515715 Jun 1995 WO
9614032 May 1996 WO
9620655 Jul 1996 WO
9622735 Aug 1996 WO
9630072 Oct 1996 WO
9718746 May 1997 WO
9725927 Jul 1997 WO
9726034 Jul 1997 WO
9738748 Oct 1997 WO
9739688 Oct 1997 WO
9748436 Dec 1997 WO
9807375 Feb 1998 WO
9824372 Jun 1998 WO
9830153 Jul 1998 WO
9832382 Jul 1998 WO
9835638 Aug 1998 WO
9900059 Jan 1999 WO
9901377 Jan 1999 WO
9907295 Feb 1999 WO
9907354 Feb 1999 WO
9913777 Mar 1999 WO
9944524 Sep 1999 WO
9966967 Dec 1999 WO
0002489 Jan 2000 WO
0003651 Jan 2000 WO
0003759 Jan 2000 WO
0012168 Mar 2000 WO
0044313 Aug 2000 WO
0059382 Oct 2000 WO
0060995 Oct 2000 WO
0100111 Jan 2001 WO
0100114 Jan 2001 WO
0103651 Jan 2001 WO
0126557 Apr 2001 WO
0126586 Apr 2001 WO
0126587 Apr 2001 WO
0126588 Apr 2001 WO
0126703 Apr 2001 WO
0128432 Apr 2001 WO
0128455 Apr 2001 WO
0147438 Jul 2001 WO
0149213 Jul 2001 WO
0150985 Jul 2001 WO
0154618 Aug 2001 WO
0156512 Aug 2001 WO
0166001 Sep 2001 WO
0170320 Sep 2001 WO
0189440 Nov 2001 WO
0195831 Dec 2001 WO
0195832 Dec 2001 WO
0197741 Dec 2001 WO
0200099 Jan 2002 WO
0201999 Jan 2002 WO
0203892 Jan 2002 WO
0234167 May 2002 WO
0260352 Aug 2002 WO
0262263 Aug 2002 WO
0262270 Aug 2002 WO
0262408 Aug 2002 WO
0301893 Jan 2003 WO
0303930 Jan 2003 WO
0320179 Mar 2003 WO
0328558 Apr 2003 WO
0337171 May 2003 WO
0347467 Jun 2003 WO
0349619 Jun 2003 WO
0373910 Sep 2003 WO
0373913 Sep 2003 WO
0382129 Oct 2003 WO
2003105667 Dec 2003 WO
2004004607 Jan 2004 WO
2004006810 Jan 2004 WO
2004012583 Feb 2004 WO
2004012789 Feb 2004 WO
2004014282 Feb 2004 WO
2004019811 Mar 2004 WO
2004030570 Apr 2004 WO
2004037317 May 2004 WO
2004045370 Jun 2004 WO
2004045378 Jun 2004 WO
2004045463 Jun 2004 WO
2004047679 Jun 2004 WO
2004062725 Jul 2004 WO
2004082523 Sep 2004 WO
2004082538 Sep 2004 WO
2004093730 Nov 2004 WO
2004103162 Dec 2004 WO
2004112585 Dec 2004 WO
2004112651 Dec 2004 WO
2005002424 Jan 2005 WO
2005018507 Mar 2005 WO
2005027797 Mar 2005 WO
2005032421 Apr 2005 WO
2005062931 Jul 2005 WO
2005112792 Dec 2005 WO
2006037073 Apr 2006 WO
2006105008 Oct 2006 WO
2006105009 Oct 2006 WO
2006113906 Oct 2006 WO
2006115875 Nov 2006 WO
2006115876 Nov 2006 WO
2007136829 Nov 2007 WO
2008103722 Aug 2008 WO
2010024801 Mar 2010 WO
2010121076 Oct 2010 WO
2012020521 Feb 2012 WO
2013049734 Apr 2013 WO
2013103934 Jul 2013 WO
2014064694 May 2014 WO
2014121280 Aug 2014 WO
2016022797 Feb 2016 WO
2016144708 Sep 2016 WO
2016150806 Sep 2016 WO
2017223073 Dec 2017 WO
2018009718 Jan 2018 WO
2018106482 Jun 2018 WO
2018236766 Dec 2018 WO
2019040943 Feb 2019 WO
2019195336 Oct 2019 WO
Non-Patent Literature Citations (125)
Entry
Nishimura, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. Jun. 10, 2014; 63(22):2438-88.
Park et al, Clinical Use of Blade Atrial Septostomy, Circulation, 1978, pp. 600-608, vol. 58.
Patel et al., #57 Epicardial Atrial Defibrillation: Novel Treatment of Postoperative Atrial Fibrillation, 2003 STS Presentation, [Abstract Only].
Privitera et al., “Alfieri Mitral Valve Repair: Clinical Outcome and Pathology,” Circulation, 106:e173-e174 (2002).
Redaelli et al., “A Computational Study of the Hemodynamics After ‘Edge-To-Edge’ Mitral Valve Repair,” Journal of Biomechanical Engineering, 123:565-570 (2001).
Reul et al., “Mitral Valve Reconstruction for Mitral Insufficiency,” Progress in Cardiovascular Diseases, XXXIX(6):567-599 (1997).
Ricchi et al, Linear Segmental Annuloplasty for Mitral Valve Repair, Ann. Thorac. Surg., Jan. 7, 1997, pp. 1805-1806, vol. 63.
Robicsek et al., #60 The Bicuspid Aortic Valve: How Does It Function? Why Does It Fail? 2003 STS Presentation, [Abstract Only].
Rose et al., “Late MitraClip Failure: Removal Technique for Leaflet-Sparing Mitral Valve Repair”, Journal of Cardiac Surgery, (Jul. 4, 2012), XP055047339, DOI: 10.1111/j. 1540-8191.2012.01483.x [retrieved on Dec. 11, 2012].
Supplemental European Search Report of EP Application No. 02746781, dated May 13, 2008, 3 pages total.
Supplementary European Search Report issued in European Application No. 05753261.6 dated Jun. 9, 2011, 3 pages total.
Tager et al, Long-Term Follow-Up of Rheumatic Patients Undergoing Left-Sided Valve Replacement With Tricuspid Annuloplasty—Validity of Preoperative Echocardiographic Criteria in the Decision to Perform Tricuspid Annuloplasty, Am. J. Cardiol., Apr. 15, 1998, pp. 1013-1016, vol. 81.
Takizawa H et al: Development of a microfine active bending catheter equipped with MIF tactile sensors“, Micro Electro Mechanical Systems, 1999. MEMS '99. Twelfth IEEE Interna Tional Conference on Orlando, FL, USA Jan. 17-21, 1999, Piscataway, NJ, USA, IEEE, US, Jan. 17, 1999 (Jan. 17, 1999), pp. 412-417, XP010321677, ISBN: 978-0-7803-5194-3 figures 1-3.”
Tamura et al., “Edge to Edge Repair for Mitral Regurgitation in a Patient with Chronic Hemodialysis: Report of a Case,” Kyobu Geka. The Japanese Journal of Thoracic Surgery, 54(9):788-790 (2001).
Tibayan et al., #59 Annular Geometric Remodeling in Chronic Ischemic Mitral Regurgitation, 2003 STS Presentation, [Abstract Only].
Timek et al., “Edge-to-edge mitral repair: gradients and three-dimensional annular dynamics in vivo during inotropic stimulation,” Eur J. of Cardiothoracic Surg., 19:431-437 (2001).
Timek, “Edge-to-Edge Mitral Valve Repair without Annuloplasty Ring in Acute Ischemic Mitral Regurgitation,” [Abstract] Clinical Science, Abstracts from Scientific Sessions, 106(19):2281 (2002).
Totaro, “Mitral valve repair for isolated prolapse of the anterior leaflet: an 11-year follow-up,” European Journal of Cardio-thoracic Surgery, 15:119-126 (1999).
U.S. Provisional Application Filed on Jul. 6, 2016, by Khairkhahan., U.S. Appl. No. 62/359,121.
U.S. Provisional Application Filed on Nov. 7, 2016, by Khairkhahan., U.S. Appl. No. 62/418,571.
U.S. Provisional Application Filed on Oct. 22, 2018, by Dale et al., U.S. Appl. No. 62/748,947.
Uchida et al, Percutaneous Cardiomyotomy and Valvulotomy with Angioscopic Guidance, Am. Heart J., Apr. 1991, pp. 1221-1224, vol. 121.
Umana et al, ‘Bow-Tie’ Mitral Valve Repair: An Adjuvant Technique for Ischemic Mitral Regurgitation, Ann. Thorac. Surg., May 12, 1998, pp. 1640-1646, vol. 66.
Umana et al., “‘Bow-tie’ Mitral Valve Repair Successfully Addresses Subvalvular Dysfunction in Ischemic Mitral Regurgitation,” Surgical Forum, XLVIII:279-280 (1997).
U.S. Appl. No. 14/216,813, filed Mar. 17, 2014, Hernandez.
Votta et al., “3-D Computational Analysis of the Stress Distribution on the Leaflets after Edge-to-Edge Repair of Mitral Regurgitation,” Journal of Heart Valve Disease, 11:810-822 (2002).
Abe et al, “De Vega's Annuloplasty for Acquired Tricuspid Disease: Early and Late Results in 110 Patients”, Ann. Thorac. Surg., pp. 670-676, vol. 48 (Jan. 1989).
Abe et al., “Updated in 1996—De Vega's Annuloplasty for Acquired Tricuspid Disease: Early and Late Results in 110 Patients”, Ann. Thorac. Surg., pp. 1876-1877, vol. 62 (1996).
Agricola et al., “Mitral Valve Reserve in Double Orifice Technique: an Exercise Echocardiographic Study,” Journal of Heart Valve Disease, 11(5):637-643 (2002).
Alfieri et al., “An Effective Technique to Correct Anterior Mitral Leaflet Prolapse,” J. Card Surg., 14:468-470 (1999).
Alfieri et al., “Novel Suture Device for Beating Heart Mitral Leaflet Approximation,” Annals of Thoracic Surgery, 74:1488-1493 (2002).
Alfieri et al., “The double orifice technique in mitral valve repair: a simple solution for complex problems,” Journal of Thoracic and Cardiovascular Surgery, 122:674-681 (2001).
Alfieri et al., “The Edge to Edge Technique,” The European Association For Cardio-Thoracic Surgery, 14th Annual Meeting, Frankfurt/ Germany, Oct. 7-11, 2000, Post Graduate Courses, Book of Proceedings.
Alfieri, “The Edge-to-Edge Repair of the Mitral Valve,” [Abstract] 6th Annual New Era Cardiac Care: Innovation & Technology, Heart Surgery Forum, (Jan. 2003) pp. 103.
Ali Khan et al, Blade Atrial Septostomy: Experience with the First 50 Procedures, Cathet. Cardiovasc. Diagn., Aug. 1991, pp. 257-262, vol. 23.
Alvarez et al, Repairing the Degenerative Mitral Valve: Ten to Fifteen-year Follow-up, Journal Thoracic of Cardiovascular Surgery, Aug. 1996, pp. 238-247, vol. 112, No. 2.
Arisi et al., “Mitral Valve Repair with Alfieri Technique in Mitral Regurgitation of Diverse Etiology: Early Echocardiographic Results,” Circulation Supplement II, 104(17):3240 (2001).
Bach et al, Early Improvement in Congestive Heart Failure After Correction of Secondary Mitral Regurgitation in End-stage Cardiomyopathy, American Heart Journal, Jun. 1995, pp. 1165-1170, vol. 129, No. 6.
Bach et al, Improvement Following Correction of Secondary Mitral Regurgitation in End-stage Cardiomyopathy With Mitral Annuloplasty, Am. J. Cardiol., Oct. 15, 1996, pp. 966-969, vol. 78.
Bailey, “Mitral Regurgitation” in Surgery of the Heart, Chapter 20, pp. 686-737 (1955).
Bernal et al., “The Valve Racket: a new and different concept of atrioventricular valve repair,” Eur. J. Cardio-thoracic Surgery 29:1026-1029 (2006).
Bhudia et al., “Edge-to-Edge (Alfieri) Mitral Repair: Results in Diverse Clinical Settings,” Ann Thorac Surg, 77:1598-1606 (2004).
Bhudia, #58 Edge-to-edge mitral repair: a versatile mitral repair technique, 2003 STS Presentation, [Abstract Only], 2004.
Bolling et al, Surgery for Acquired Heart Disease: Early Outcome of Mitral Valve Reconstruction in Patients with End-stage Cardiomyopathy, Journal of Thoracic and Cariovascular Surgery, Apr. 1995, pp. 676-683, vol. 109, No. 4.
Borghetti et al., “Preliminary observations on haemodynamics during physiological stress conditions following ‘double-orifice’ mitral valve repair,” European Journal of Cardio-thoracic Surgery, 20:262-269 (2001).
Castedo, “Edge-to-Edge Tricuspid Repair for Redeveloped Valve Incompetence after DeVega's Annuloplasty,” Ann Thora Surg., 75:605-606 (2003).
Chinese Office Action issued in Chinese Application No. 200980158707.2 dated Sep. 9, 2013.
Communication dated Apr. 16, 2018 from the European Patent Office in counterpart European application No. 04752603.3.
Communication dated Apr. 28, 2017 issued by the European Patent Office in counterpart application No. 16196023.2.
Communication dated Jan. 26, 2017, from the European Patent Office in counterpart European application No. 16196023.2.
Communication dated May 8, 2017, from the European Patent Office in counterpart European Application No. 04752714.8.
Dang N C et al., “Surgical Revision After Percutaneous Mitral Valve Repair with a Clip: Initial Multicenter Experience”, The Annals of Thracic Surgery, Elsevier, United States, vol. 80, No. 6, pp. 2338-2342, (Dec. 1, 2005), XP027732951, ISSN:0003-4975 [retrieved on Dec. 1, 2005].
Dec et al, Idiopathic Dilated Cardiomyopathy, The New England Journal of Medicine, Dec. 8, 1994, pp. 1564-1575, vol. 331, No. 23.
Dottori et al., “Echocardiographic imaging of the Alfieri type mitral valve repair,” Ital. Heart J., 2(4):319-320 (2001).
Downing et al., “Beating heart mitral valve surgery: Preliminary model and methodology,” Journal of Thoracic and Cardiovascular Surgery, 123(6):1141-1146 (2002).
Extended European Search Report, dated Oct. 17, 2014, issued in European Patent Application No. 06751584.1.
Falk et al., “Computer-Enhanced Mitral Valve Surgery: Toward a Total Endoscopic Procedure,” Seminars in Thoracic and Cardiovascular Surgery, 11(3):244-249 (1999).
Feldman, et al. Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of Everest Ii. J Am Coll Cardiol. Dec. 29, 2015;66(25):2844-2854.
Filsoufi et al., “Restoring Optimal Surface of Coaptation With a Mini Leaflet Prosthesis: A New Surgical Concept for the Correction of Mitral Valve Prolapse,” Intl. Soc. for Minimally Invasive Cardiothoracic Surgery 1(4):186-87 (2006).
Frazier et al., #62 Early Clinical Experience with an Implantable, Intracardiac Circulatory Support Device: Operative Considerations and Physiologic Implications, 2003 STS Presentation, 1 page total. [Abstract Only].
Fucci et al, Improved Results with Mitral Valve Repair Using New Surgical Techniques, Eur. J. Cardiothorac. Surg., Nov. 1995, pp. 621-627, vol. 9.
Fundaro et al., “Chordal Plication and Free Edge Remodeling for Mitral Anterior Leaflet Prolapse Repair: 8-Year Follow-up,” Annals of Thoracic Surgery, 72:1515-1519 (2001).
Garcia-Rinaldi et al., “Left Ventricular vol. Reduction and Reconstruction is Ischemic Cardiomyopathy,” Journal of Cardiac Surgery, 14:199-210 (1999).
Gateliene, “Early and postoperative results results of metal and tricuspid valve insufficiency surgical treatment using edge-to-edge central coaptation procedure,” (Oct. 2002) 38 (Suppl 2):172 175.
Gatti et al., “The edge to edge technique as a trick to rescue an imperfect mitral valve repair,” Eur. J. Cardiothorac Surg, 22:817-820 (2002).
Gundry, “Facile mitral valve repair utilizing leaflet edge approximation: midterm results of the Alfieri figure of eight repair,” Presented at the Meeting of the Western Thoracic Surgical Association, (1999).
Gupta et al., #61 Influence of Older Donor Grafts on Heart Transplant Survival: Lack of Recipient Effects, 2003 STS Presentation, [Abstract Only].
Ikeda et al., “Batista's Operation with Coronary Artery Bypass Grafting and Mitral Valve Plasty for Ischemic Dilated Cardiomyopathy,” The Japanese Journal of Thoracic and Cardiovascular Surgery, 48:746-749 (2000).
Izzat et al., “Early Experience with Partial Left Ventriculectomy in the Asia-Pacific Region,” Annuals of Thoracic Surgery, 67:1703-1707 (1999).
Kallner et al., “Transaortic Approach for the Alfieri Stitch,” Ann Thorac Surg, 71:378-380 (2001).
Kameda et al., Annuloplasty for Severe Mitral Regurgitation Due to Dilated Cardiomyopathy, Ann. Thorac. Surg., 1996, pp. 1829-1832, vol. 61.
Kavarana et al., “Transaortic Repair of Mitral Regurgitation,” The Heart Surgery Forum, #2000-2389, 3(1):24-28 (2000).
Kaza et al., “Ventricular Reconstruction Results in Improved Left Ventricular Function and Amelioration of Mitral Insufficiency,” Annals of Surgery, 235(6):828-832 (2002).
Khan et al., “Blade Atrial Septostomy; Experience with the First 50 Procedures”, Catheterization and Cardiovascular Diagnosis, 23:257-262 (1991).
Kherani et al., “The Edge-To-Edge Mitral Valve Repair: The Columbia Presbyterian Experience,” Ann. Thorac. Surg., 78:73-76 (2004).
Kron et al., “Surgical Relocation of the Posterior Papillary Muscle in Chronic Ischemic Mitral Regurgitation,” Annals. Of Thoracic Surgery, 74:600-601 (2002).
Kruger et al., “P73—Edge to Edge Technique in Complex Mitral Valve Repair,” Thorac Cardiovasc Surg., 48(Suppl. 1):106 (2000).
Langer et al., “Posterier mitral leaflet extensions: An adjunctive repair option for ischemic mitral regurgitation?” J Thorac Cardiovasc Surg, 131:868-877 (2006).
Lorusso et al., “The double-orifice technique for mitral valve reconstruction: predictors of postoperative outcome,” Eur J. Cardiothorac Surg, 20:583-589 (2001).
Maisano et al., The Edge-to-edge Technique: A Simplified Method to Correct Mitral Insufficiency, Eur. J. Cardiothorac. Surg., Jan. 14, 1998, pp. 240-246, vol. 13.
Maisano et al, The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? Eur Heart J. Jul. 7, 2015; 36(26):1651-1659.
Maisano et al., “The double orifice repair for Barlow Disease: a simple solution for a complex repair,” Supplement I Circulation, (Nov. 1999); 100(18):1-94.
Maisano et al., “The double orifice technique as a standardized approach to treat mitral regurgitation due to severe myxomatous disease: surgical technique,” European Journal of Cardio-thoracic Surgery, 17:201-205 (2000).
Maisano et al., “The Future of Transcatheter Mitral Valve Interventions: Competitive or Complementary Role of Repair vs. Replacement?”, Eur Heart J.36(26):1651-1659 ( Jul. 7, 2015 ).
Maisano et al., “The hemodynamic effects of double-orifice valve repair for mitral regurgitation: a 3D computational model,” European Journal of Cardio-thoracic Surgery, 15:419-425 (1999).
Maisano et al., “Valve repair for traumatic tricuspid regurgitation,” Eur. J. Cardio-thorac Surg, (1996) 10:867-873.
Mantovani et al., “Edge-to-edge Repair of Congenital Familiar Tricuspid Regurgitation: Case Report,” J. Heart Valve Dis., 9:641-643 (2000).
McCarthy et al, “Tricuspid Valve Repair With the Cosgrove-Edwards Annuloplasty System”, Ann. Thorac. Surg., 64:267-8 ( Jan. 16, 1997).
McCarthy et al., “Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure,” European Journal of Cardio-thoracic Surgery, 13:337-343 (1998).
McCarthy et al., “Tricuspid Valve Repair With the Cosgrove-Edwards Annuloplasty System”, Ann. Throac Surg. 64:267-8 (Jan. 16, 1997).
Moainie et al., “Correction of Traumatic Tricuspid Regurgitation Using the Double Orifice Technique,” Annals of Thoracic Surgery, 73:963-965 (2002).
Morales et al., “Development of an Off Bypass Mitral Valve Repair,” The Heart Surgery Forum #1999-4693, 2(2):115-120 (1999).
Nakanishi et al., “Early Outcome with the Alfieri Mitral Valve Repair,” J. Cardiol., 37: 263-266 (2001) [Abstract in English; Article in Japanese].
Nielsen et al., “Edge-to-Edge Mitral Repair: Tension of the Approximating Suture and Leaflet Deformation During Acute Ischemic Mitral Regurgitation in the Ovine Heart,” Circulation, 104(Suppl. 1):1-29-1-35 (2001).
Noera et al., “Tricuspid Valve Incompetence Caused by Nonpenetrating Thoracic Trauma”, Annals of Thoracic Surgery, 51:320-322 (1991).
Notice of Allowance received for U.S. Appl. No. 14/216,787, filed Nov. 7, 2016.
Notice of Allowance received for U.S. Appl. No. 14/216,787, mailed on Nov. 7, 2016.
Notice of Allowance received for U.S. Appl. No. 14/577,852, filed Apr. 25, 2018.
Notice of Allowance received for U.S. Appl. No. 14/577,852, mailed on Apr. 25, 2018.
Notice of Allowance received for U.S. Appl. No. 15/642,245, mailed on Jan. 29, 2020.
Notice of Allowance received for U.S. Appl. No. 15/642,245, mailed on Mar. 27, 2020.
Notice of Allowance received for U.S. Appl. No. 15/642,245, mailed on Nov. 6, 2019.
Notice of Allowance received for U.S. Appl. No. 15/423,060, mailed on Jan. 27, 2020.
Office Action received for U.S. Appl. No. 14/216,787, filed Apr. 8, 2016.
Office Action received for U.S. Appl. No. 14/216,787, mailed on Apr. 8, 2016.
Office Action received for U.S. Appl. No. 14/216,813, filed Apr. 6, 2018.
Office Action received for U.S. Appl. No. 14/216,813, filed Dec. 15, 2017.
Office Action received for U.S. Appl. No. 14/216,813, filed Mar. 9, 2017.
Office Action received for U.S. Appl. No. 14/216,813, mailed on Apr. 6, 2018.
Office Action received for U.S. Appl. No. 14/216,813, mailed on Dec. 15, 2017.
Office Action received for U.S. Appl. No. 14/216,813, mailed on Mar. 9, 2017.
Office Action received for U.S. Appl. No. 14/577,852, filed May 16, 2017.
Office Action received for U.S. Appl. No. 14/577,852, filed Oct. 20, 2016.
Office Action received for U.S. Appl. No. 14/577,852, filed Sep. 7, 2017.
Office Action received for U.S. Appl. No. 14/577,852, mailed on May 16, 2017.
Office Action received for U.S. Appl. No. 14/577,852, mailed on Oct. 20, 2016.
Office Action received for U.S. Appl. No. 14/577,852, mailed on Sep. 7, 2017.
Office Action received for U.S. Appl. No. 15/423,060, mailed on Apr. 25, 2019.
Office Action received for U.S. Appl. No. 15/423,060, mailed on Aug. 19, 2019.
Office Action received for U.S. Appl. No. 15/423,060, mailed on Oct. 28, 2019.
Office Action received for U.S. Appl. No. 15/642,245, mailed on Aug. 9, 2019.
Office Action received for U.S. Appl. No. 15/724,545, filed Dec. 27, 2019.
Office Action received for U.S. Appl. No. 15/724,545, mailed on Dec. 27, 2019.
Office Action received for U.S. Appl. No. 15/724,545, mailed on May 1, 2020.
Osawa et al., “Partial Left Ventriculectomy in a 3-Year Old Boy with Dilated Cardiomyopathy,” Japanese Journal of Thoracic and Cardiovascular Surg, 48:590-593 (2000).
Related Publications (1)
Number Date Country
20210346090 A1 Nov 2021 US
Provisional Applications (1)
Number Date Country
63020671 May 2020 US